Our Products

We offer a comprehensive range of innovative pharmaceutical products across oncology, metabolic diseases, and infectious diseases.

ALK-positive metastatic non-small cell lung cancer treatment

MET inhibitor for metastatic NSCLC with MET exon 14 skipping mutations

Oral GLP-1 receptor agonist for type 2 diabetes and weight management

Dual GIP/GLP-1 receptor agonist for diabetes and chronic weight management

GLP-1 receptor agonist for type 2 diabetes, weight management, and cardiovascular risk reduction

HIV capsid inhibitor for multi-drug resistant HIV-1 and PrEP